DENTSPLY SIRONA Inc. (XRAY) › Analysis

DENTSPLY SIRONA Inc. (XRAY) analysis, February 11, 2026

Published February 11, 2026 · XRAY chart, levels and live analysis

Key Updates

DENTSPLY SIRONA has retreated -2.21% to $13.71 since the February 10 report, representing a modest consolidation following the sharp rally that pushed the stock above $14. Despite this pullback, YTD performance remains robust at +19.95%, and the recent decline appears to be a technical correction rather than a fundamental reversal. The stock has maintained support above the $13.50 level, preserving most of the gains from the late January breakout. Market research from MarketsandMarkets confirms XRAY's positioning in three high-growth dental market segments, though competitive pressure from 3Shape's award-winning TRIOS 6 scanner highlights intensifying technology competition in the intraoral scanning space.

Current Trend

DENTSPLY SIRONA exhibits a strong uptrend across all timeframes, with the current pullback representing healthy profit-taking after a 22.6% rally from late January lows. The stock has gained +9.33% over 5 days, +9.68% over 1 month, and +9.42% over 6 months, demonstrating consistent momentum. The YTD gain of +19.95% significantly outperforms the broader market and reflects a decisive shift in investor sentiment. The $13.50-$13.70 zone is emerging as near-term support, while the recent $14.02 high represents immediate resistance. The stock has successfully held above the psychologically important $13 level, which previously acted as resistance in early January. Price action suggests consolidation within a $13.50-$14.50 range as the market digests recent gains before potentially testing higher levels.

Investment Thesis

The investment thesis centers on DENTSPLY SIRONA's exposure to multiple high-growth dental technology markets driven by demographic tailwinds and digital transformation. The company operates in three expanding market segments: dental equipment ($11.48 billion by 2031), digital dentures ($2.39 billion by 2031 at 6.7% CAGR), and dental bone graft substitutes ($2.04 billion by 2031 at 6.5% CAGR). All three markets benefit from aging populations, increasing dental disease prevalence, and technological advancement. XRAY's comprehensive product portfolio positions it to capture growth across therapeutic equipment, CAD/CAM systems, 3D printing, and regenerative materials. The thesis assumes the company can maintain market share despite intensifying competition from specialized players like 3Shape and Align Technology, while leveraging its scale advantage in hospitals and clinics that represent the largest end-user segments across all three markets.

Thesis Status

The investment thesis remains intact and receives validation from recent market research, though competitive dynamics present execution risk. The three MarketsandMarkets reports published February 6-10 confirm robust growth trajectories in XRAY's core markets, with North America maintaining 38.8-40% market share where DENTSPLY SIRONA has established presence. The company's identification as a key player across all three market segments demonstrates its diversified exposure to industry growth drivers. However, 3Shape's TRIOS 6 scanner winning the European Product Design Award 2025 with 110% higher scan resolution represents a competitive threat in the critical intraoral scanning category, potentially pressuring XRAY's market share in digital dentistry equipment. The thesis assumes XRAY can compete through its broader product ecosystem and established hospital relationships, but the technology gap highlighted by 3Shape's award-winning innovation suggests XRAY must accelerate R&D investment to maintain competitive parity.

Key Drivers

Three primary drivers support the bullish outlook. First, demographic trends create structural demand growth, with aging populations experiencing increased tooth loss and periodontal disease, driving demand for dental implants, bone grafts, and dentures across XRAY's product portfolio (PR Newswire, Feb 10). Second, digital transformation accelerates adoption of CAD/CAM systems, intraoral scanners, and 3D printing, with the digital denture market growing at 6.7% CAGR as dental practices shift toward faster, more accurate digital workflows (PR Newswire, Feb 6). Third, hospitals and clinics represent the largest end-user segment due to their advanced infrastructure and high patient volumes, favoring established players like DENTSPLY SIRONA that can provide comprehensive solutions (PR Newswire, Feb 9). The competitive threat emerges from 3Shape's technological advancement, with the TRIOS 6 scanner delivering superior resolution and AI-assisted diagnostics, potentially capturing market share from XRAY's scanning solutions (PR Newswire, Feb 2).

Technical Analysis

DENTSPLY SIRONA trades at $13.71, down -1.58% on the day but maintaining the broader uptrend structure. The stock has established a new support zone at $13.50-$13.70 following the late January breakout, with resistance at the recent $14.02 high. The -2.21% decline since the February 10 report represents normal consolidation after the 22.6% rally from late January lows, with volume patterns suggesting profit-taking rather than distribution. Key technical levels include support at $13.50 (5-day low), $13.00 (psychological level and former resistance), and $12.50 (1-month breakout point). Resistance appears at $14.00 (recent high), $14.50 (next technical target), and $15.00 (round number). The stock's ability to hold above $13.50 during this pullback demonstrates underlying strength, while the YTD gain of +19.95% establishes positive momentum. A break above $14.00 on strong volume would signal continuation toward $14.50-$15.00, while a failure below $13.50 could trigger retracement toward $13.00.

Bull Case

Bear Case

Get a message when the XRAY picture changes — the agent team watches the levels and the news for you.Create a free account

XRAY chart and key levels · XRAY earnings date and past reactions · Earnings this week

More XRAY analyses